Nebulized morphine in the palliation of dyspnoea
- 1 July 1997
- journal article
- research article
- Published by SAGE Publications in Palliative Medicine
- Vol. 11 (4) , 267-275
- https://doi.org/10.1177/026921639701100402
Abstract
Seventeen terminally ill cancer patients with primary or secondary intra- thoracic malignancy complaining of breathlessness were treated with nebulized morphine in doses of 20 mg 4-hourly for 48 h. The effect on dyspnoea was evaluated using the Dyspnoea Assessment Questionnaire. Most patients felt less dyspnoeic after 24 h; the effect was maintained, but not improved upon, after 48 h.Keywords
This publication has 21 references indexed in Scilit:
- The use of nebulized opioids for breathlessness: a chart reviewPalliative Medicine, 1994
- Nebulised morphineThe Lancet, 1993
- Effects of Nebulized Morphine Sulfate on the Exercise Tolerance of the Ventilatory Limited COPD PatientChest, 1993
- Case studies outlining use of nebulized morphine for patients with end-stage chronic lung and cardiac diseaseJournal of Pain and Symptom Management, 1993
- Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group.Thorax, 1993
- Peripheral opioid receptors and the cough reflexRespiratory Medicine, 1991
- How much of a problem is dyspnoea in advanced cancer?Palliative Medicine, 1991
- Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease.Thorax, 1989
- OPIOID INHIBITION OF NEURALLY MEDIATED MUCUS SECRETION IN HUMAN BRONCHIThe Lancet, 1989
- Dyspnea in Terminally Ill Cancer PatientsChest, 1986